Not all dopamine neurons are equally vulnerable to degeneration in idiopathic Parkinson's disease (PD). """"""""Nigrosomes"""""""" of substantia nigra pars compacts are most vulnerable with nigral matrix, retrorubral area and ventral tegmental area next in vulnerability while hypothalamic and periaqueductal gray neurons are resistant to the degenerative process. This project will test the hypothesis that the dopamine neurons most vulnerable to parkinsonian degeneration differ from relatively resistant neurons by having higher concentrations of molecules that make them vulnerable to degeneration (alpha-synuclein, recently found to be mutated in some PD families and to be present in Lewy bodies; parkin, recently found to be mutated in autosomal recessive-juvenile parkinsonism; torsinA, the dopamine neuron chaperonin that is mutated in early onset torsion dystonia; or dopamine transporters). The newly developed double-label in situ hybridization histochemistry and antisense RNA techniques will be used to compare the gene expression rates of these compounds in the different subgroups of dopamine neurons in control brains and in the brains of persons dying with PD. In collaboration with projects 1, 2 and 4, ligand binding studies will be done to study dopamine and GABA function in the basal ganglia of mice transgenic for the alpha-synuclein and torsinA mutations. These experiments are important for testing the overall hypothesis that specific molecules are important to PD pathogenesis since they will link these molecules directly to the effected neurons while generalized evidence for changes in their expression in PD might be a result from rather a cause of the disease process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
3P50NS038372-01S1
Application #
6112669
Study Section
Project Start
1998-09-30
Project End
1999-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Caraveo, Gabriela; Soste, Martin; Cappelleti, Valentina et al. (2017) FKBP12 contributes to ?-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. Proc Natl Acad Sci U S A 114:E11313-E11322
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80
Nuytemans, Karen; Inchausti, Vanessa; Beecham, Gary W et al. (2014) Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Mov Disord 29:827-30
Hernandez, Ledia F; Kubota, Yasuo; Hu, Dan et al. (2013) Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci 33:4782-95
Lemaire, Nuné; Hernandez, Ledia F; Hu, Dan et al. (2012) Effects of dopamine depletion on LFP oscillations in striatum are task- and learning-dependent and selectively reversed by L-DOPA. Proc Natl Acad Sci U S A 109:18126-31
Tardiff, Daniel F; Tucci, Michelle L; Caldwell, Kim A et al. (2012) Different 8-hydroxyquinolines protect models of TDP-43 protein, ?-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287:4107-20
Klucken, Jochen; Poehler, Anne-Maria; Ebrahimi-Fakhari, Darius et al. (2012) Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8:754-66
Lin, Michael T; Cantuti-Castelvetri, Ippolita; Zheng, Kangni et al. (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol 71:850-4
Farabaugh, Amy H; Locascio, Joseph J; Yap, Liang et al. (2011) Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. Ann Clin Psychiatry 23:171-7
Chen-Plotkin, Alice S; Martinez-Lage, Maria; Sleiman, Patrick M A et al. (2011) Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol 68:488-97

Showing the most recent 10 out of 87 publications